{"id":"W2098499757","doi":"10.1016/s1470-2045(12)70509-0","title":"Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Genentech","keywords":"Bevacizumab; Medicine; Oxaliplatin; Capecitabine; Colorectal cancer; Clinical endpoint; Internal medicine; Bolus (digestion); Chemotherapy; Fluorouracil; Surgery; Gastroenterology; Phases of clinical research; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002760219,0.002157807,0.003918567,0.0005036243,0.0005314476,0.001459597,0.001121197,0.002349406,0.008428083],"category_scores_gemma":[0.003001192,0.0009565841,0.003544991,0.0006957017,0.00142556,0.001401534,0.0005844925,0.003721613,0.001039698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001093478,"about_ca_system_score_gemma":0.001411032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002069714,"about_ca_topic_score_gemma":0.004233519,"domain_scores_codex":[0.9988494,0.0006590186,0.00008446281,0.0001862965,0.00007324775,0.0001476133],"domain_scores_gemma":[0.998688,0.0004480194,0.0003295511,0.0001109872,0.0000823954,0.0003409984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9898084,0.001119239,0.0001356768,0.001080007,0.001191126,0.00001991386,0.00002945726,0.0001857415,0.0007686868,0.00009322778,0.0005442261,0.005024274],"study_design_scores_gemma":[0.9853923,0.01298063,0.0002959839,0.00004618052,0.000654464,0.00001167868,0.000008563386,0.0001054143,0.00007378584,0.00008727526,0.0003367915,0.000006979481],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9432797,0.03141207,0.002345658,0.002718192,0.003260269,0.009275374,0.002963135,0.0003112845,0.00443423],"genre_scores_gemma":[0.9625772,0.01274906,0.004153533,0.002479234,0.001099253,0.008784409,0.001908393,0.00006873673,0.006180256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008428083,"threshold_uncertainty_score":0.02819479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0801800099192156,"score_gpt":0.4280330432983145,"score_spread":0.3478530333790989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}